Researchers have uncovered insights into the potential mechanism of action of the antipsychotic medication asenapine, a possible therapeutic target for substance use and neuropsychiatric disorders. This discovery may pave the way for the development of improved medications targeting the same pathway.
Their findings, detailed in the journal Nature Communications show that a brain protein known as the TAAR1 receptor, a drug target known to regulate dopamine signaling in key reward pathways in the brain, differs significantly in humans compared to the preclinical rodent models on which drugs are typically tested.
The study suggests considering species-specific differences in drug-receptor interactions and further investigation into ways asenapine affects the body, as steps toward potential therapeutic improvements.
"In investigating the functional and structural properties of TAAR1, our study aimed to shed more light on its mechanisms and pharmacology,” says study first author. “Our findings may guide the development of novel TAAR1 drugs and prompt more exploration of medications similar to asenapine.”
Using advanced techniques to investigate TAAR1’s structure and function, the researchers identified three important elements. First, there are differences between rodent and human TAAR1 that likely affect how preclinical model studies can be translated to humans. Second, TAAR1 is much more closely related to serotonin and dopamine receptors than previously assumed. This suggests that several serotonin-targeting medications might have unknown therapeutic efficacy or side effects that are in fact due to their actions at TAAR1.
Finally, the investigators highlight that the clinically used antipsychotic asenapine unexpectedly shows strong activation of TAAR1, suggesting in fact that this serotonin- and dopamine-targeting antipsychotic could derive some of its therapeutic effects from TAAR1 activation. If proven in further studies, this could open up new possibilities for its potential in other TAAR1-related therapeutic applications such as its use in substance use disorders, as well as the development of new asenapine-based drugs.
The researchers noted the absence of information about differences in how TAAR1 works in rodents and humans, and emphasized that some of these differences could account for why preclinical data on TAAR1 has not yet been successfully translated into effective therapies in humans. Next, the researchers plan to study where TAAR1 is located within cells and what its precise role is in influencing serotonin and dopamine signaling.
“This study provides a significant leap in understanding TAAR1, offering potential avenues for drug development and encouraging further research into its therapeutic applications,” says the senior author. "As our work advances, we anticipate it may play a crucial role in shaping the development of new drugs targeting TAAR1 and offering valuable insights into how drugs similar to asenapine might work."
https://www.nature.com/articles/s41467-023-44601-4
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Fmolecular-basis-of_3&filter=22
Crystal structure of a receptor linked to neuropsychiatric disorders unraveled!
- 1,093 views
- Added
Latest News
Maternal obesity may promot…
By newseditor
Posted 30 May
The neuronal basis of opioi…
By newseditor
Posted 30 May
Circadian clock can be leve…
By newseditor
Posted 30 May
Connecting genetic risk for…
By newseditor
Posted 30 May
Tumor infiltration of immun…
By newseditor
Posted 28 May
Other Top Stories
Gut fungi linked to higher Alzheimer's risk can be treated with ket…
Read more
Mini proteins to treat COVID-19
Read more
Middle-aged individuals may be in a perpetual state of H3N2 flu vir…
Read more
Warmth Prevents Bone Loss Through the Gut Microbiota
Read more
Hyperinflammatory syndrome in children with COVID-19 is different f…
Read more
Protocols
Accessible high-speed image…
By newseditor
Posted 30 May
SEMORE: SEgmentation and MO…
By newseditor
Posted 26 May
Spatially resolved lipidomi…
By newseditor
Posted 24 May
Efficient expansion and CRI…
By newseditor
Posted 21 May
Massively parallel in vivo…
By newseditor
Posted 20 May
Publications
Interactions between physic…
By newseditor
Posted 30 May
Lipid-associated macrophage…
By newseditor
Posted 30 May
Maternal obesity increases…
By newseditor
Posted 30 May
Why cells need iron: a comp…
By newseditor
Posted 30 May
Distinct μ-opioid ensembles…
By newseditor
Posted 30 May
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar